Oral Chromium Exposure and Toxicity

Current environmental health reports

Volumn 2, Issue 3, 2015, Pages 295-303

  Sun, Hong ^a   Brocato, Jason ^a   Costa, Max ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Carcinogenesis; Hexavalent chromium; Oral exposure; Oxidative stress; Reduction

Indexed keywords

CARCINOGEN; CHROMIUM; CHROMIUM HEXAVALENT ION; DRINKING WATER; WATER POLLUTANT;

ANIMAL; CHEMISTRY; DNA DAMAGE; EPIGENETICS; FOOD CONTAMINATION; HUMAN; MOUSE; PHARMACOKINETICS; RAT; TOXICITY; WATER POLLUTANT;

ANIMALS; CARCINOGENS, ENVIRONMENTAL; CHROMIUM; DNA DAMAGE; DRINKING WATER; EPIGENOMICS; FOOD CONTAMINATION; HUMANS; MICE; RATS; WATER POLLUTANTS, CHEMICAL;

EID: 84993505419     PISSN: None     EISSN: 21965412     Source Type: Journal    
DOI: 10.1007/s40572-015-0054-z     Document Type: Review

References (78)

1. Costa M, Klein CB. Toxicity and carcinogenicity of chromium compounds in humans. Crit Rev Toxicol. 2006;36:155–63.
2. Langard S, and Costa M: Chapter 33: Chromium. In: Nordberg GF, Fowler BA, and Nordberg M, editors. Handbook on the toxicology of metals. Academic Press; 2014. pp. 717-742.
3. Gibb HJ, Lees PS, Pinsky PF, et al. Lung cancer among workers in chromium chemical production. Am J Ind Med. 2000;38:115–26.
4. Holmes AL, Wise SS, Wise JP. Carcinogenicity of hexavalent chromium. Indian J Med Res. 2008;128:353–72.
5. IARC. Chromium, nickel and welding. IARC monographs on the evaluation of carcinogenic risks to humans. Int Agency Res Cancer Lyon. 1990;49:49–256.
6. Zhang JD, Li XL. Chromium pollution of soil and water in Jinzhou. Zhonghua Yu Fang Yi Xue Za Zhi. 1987;21:262–4.
7. Cole P, Rodu B. Epidemiologic studies of chrome and cancer mortality: a series of meta-analyses. Regul Toxicol Pharmacol. 2005;43:225–31.
8. Gatto N, Alexander D, Kelsh M. Meta-analysis of occupational exposure to hexavalent chromium and stomach cancer. Epidemiology. 2007;18:S33.
9. Gatto NM, Kelsh MA, Mai DH, et al. Occupational exposure to hexavalent chromium and cancers of the gastrointestinal tract: a meta-analysis. Cancer Epidemiol. 2010;34:388–99.
10. National Toxicology Program: Toxicology and carcinogenesis studies of sodium dichromate dihydrate (Cas No. 7789-12-0) in F344/N rats and B6C3F1 mice (drinking water studies). Natl Toxicol Program Tech Rep Ser. 2008; 1-192.
11. Stout MD, Herbert RA, Kissling GE, et al. Hexavalent chromium is carcinogenic to F344/N rats and B6C3F1 mice after chronic oral exposure. Environ Health Perspect. 2009;117:716–22.
12. Zhitkovich A. Chromium in drinking water: sources, metabolism, and cancer risks. Chem Res Toxicol. 2011;24:1617–29.
13. Zhitkovich A. Importance of chromium-DNA adducts in mutagenicity and toxicity of chromium (VI). Chem Res Toxicol. 2005;18:3–11.
14. O’Brien T. Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms. Mutat Res/Fundam Mol Mech Mutagen. 2003;533:3–36.
15. Nickens KP, Patierno SR, Ceryak S. Chromium genotoxicity: a double-edged sword. Chem Biol Interact. 2010;188:276–88.
16. Costa M. Toxicity and carcinogenicity of Cr(VI) in animal models and humans. Crit Rev Toxicol. 1997;27:431–42.
17. Salnikow K, Zhitkovich A. Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium. Chem Res Toxicol. 2008;21:28–44.
18. World Health Organization (WHO). Chromium in drinking-water—background document for development of WHO guidelines for drinking-water quality, WHO, 2003; Geneva Switzerland.
19. Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological profile for chromium, U.S. Department of Health and Human Services, 2012; Washington, DC.
20. Sutton R, Group EW. Chromium-6 in US tap water, (Environmental Working Group). 2010.
21. Environmental Protection Agency (EPA). National primary drinking water regulations; final rule. Fed Regist. 1991;56:3536–7.
22. Suzuki Y, Fukuda K. Reduction of hexavalent chromium by ascorbic acid and glutathione with special reference to the rat lung. Arch Toxicol. 1990;64:169–76.
23. Standeven AM, Wetterhahn KE. Ascorbate is the principal reductant of chromium (VI) in rat liver and kidney ultrafiltrates. Carcinogenesis. 1991;12:1733–7.
24. Standeven AM, Wetterhahn KE. Ascorbate is the principal reductant of chromium(VI) in rat lung ultrafiltrates and cytosols, and mediates chromium-DNA binding in vitro. Carcinogenesis. 1992;13:1319–24.
25. Quievryn G, Peterson E, Messer J, et al. Genotoxicity and mutagenicity of chromium(VI)/ascorbate-generated DNA adducts in human and bacterial cells. Biochemistry. 2003;42:1062–70.
26. Yao H, Guo L, Jiang BH, et al. Oxidative stress and chromium(VI) carcinogenesis. J Environ Pathol Toxicol Oncol. 2008;27:77–88.
27. Messer J, Reynolds M, Stoddard L, et al. Causes of DNA single-strand breaks during reduction of chromate by glutathione in vitro and in cells. Free Radic Biol Med. 2006;40:1981–92.
28. Reynolds M, Stoddard L, Bespalov I, et al. Ascorbate acts as a highly potent inducer of chromate mutagenesis and clastogenesis: linkage to DNA breaks in G2 phase by mismatch repair. Nucleic Acids Res. 2007;35:465–76.
29. De Flora S, Camoirano A, Bagnasco M, et al. Estimates of the chromium(VI) reducing capacity in human body compartments as a mechanism for attenuating its potential toxicity and carcinogenicity. Carcinogenesis. 1997;18:531–7.
30. De Flora S. Threshold mechanisms and site specificity in chromium(VI) carcinogenesis. Carcinogenesis. 2000;21:533–41.
31. De Flora S, Iltcheva M, Balansky RM. Oral chromium(VI) does not affect the frequency of micronuclei in hematopoietic cells of adult mice and of transplacentally exposed fetuses. Mutat Res. 2006;610:38–47.
32. Davidson T, Kluz T, Burns F, et al. Exposure to chromium (VI) in the drinking water increases susceptibility to UV-induced skin tumors in hairless mice. Toxicol Appl Pharmacol. 2004;196:431–7.
33. Uddin AN, Burns FJ, Rossman TG, et al. Dietary chromium and nickel enhance UV-carcinogenesis in skin of hairless mice. Toxicol Appl Pharmacol. 2007;221:329–38.
34. Collins BJ, Stout MD, Levine KE, et al. Exposure to hexavalent chromium resulted in significantly higher tissue chromium burden compared with trivalent chromium following similar oral doses to male F344/N rats and female B6C3F1 mice. Toxicol Sci. 2010;118:368–79.
35. Witt KL, Stout MD, Herbert RA, et al. Mechanistic insights from the NTP studies of chromium. Toxicol Pathol. 2013;41:326–42. This study presented the major results and conclusions from two NTP Cr studies and discussed multiple potential mechanisms involved in Cr-induced genotoxicity and carcinogenicity.
36. Beaumont JJ, Sedman RM, Reynolds SD, et al. Cancer mortality in a Chinese population exposed to hexavalent chromium in drinking water. Epidemiology. 2008;19:12–23.
37. Kerger BD, Butler WJ, Paustenbach DJ, et al. Cancer mortality in Chinese populations surrounding an alloy plant with chromium smelting operations. J Toxicol Environ Health A. 2009;72:329–44.
38. Linos A, Petralias A, Christophi CA, et al. Oral ingestion of hexavalent chromium through drinking water and cancer mortality in an industrial area of Greece—an ecological study. Environ Health. 2011;10:50.
39. Sazakli E, Villanueva CM, Kogevinas M, et al. Chromium in drinking water: association with biomarkers of exposure and effect. Int J Environ Res Public Health. 2014;11:10125–45.
40. Sharma P, Bihari V, Agarwal SK, et al. Groundwater contaminated with hexavalent chromium [Cr (VI)]: a health survey and clinical examination of community inhabitants (Kanpur, India). PLoS One. 2012;7, e47877.
41. Sedman RM, Beaumont J, McDonald TA, et al. Review of the evidence regarding the carcinogenicity of hexavalent chromium in drinking water. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2006;24:155–82.
42. Thompson CM, Proctor DM, Suh M, et al. Assessment of the mode of action underlying development of rodent small intestinal tumors following oral exposure to hexavalent chromium and relevance to humans. Crit Rev Toxicol. 2013;43:244–74.
43. Borneff J, Engelhardt K, Griem W, et al. Carcinogens in water and soil. XXII. Experiment with 3,4-benzopyrene and potassium chromate in mice drink. Arch Hyg Bakteriol. 1968;152:45–53.
44. De Flora S, D’Agostini F, Balansky R, et al. Lack of genotoxic effects in hematopoietic and gastrointestinal cells of mice receiving chromium(VI) with the drinking water. Mutat Res. 2008;659:60–7.
45. Thompson CM, Proctor DM, Haws LC, et al. Investigation of the mode of action underlying the tumorigenic response induced in B6C3F1 mice exposed orally to hexavalent chromium. Toxicol Sci. 2011;123:58–70. The study shows a significant decrease in the GSH/GSSG ration in the duodenum from Cr(VI) treated mice, suggesting that oral exposure of Cr(VI) in drinking water can induce oxidative stress.
46. Thompson CM, Proctor DM, Suh M, et al. Comparison of the effects of hexavalent chromium in the alimentary canal of F344 rats and B6C3F1 mice following exposure in drinking water: implications for carcinogenic modes of action. Toxicol Sci. 2012;125:79–90.
47. Wang X, Mandal AK, Saito H, et al. Arsenic and chromium in drinking water promote tumorigenesis in a mouse colitis-associated colorectal cancer model and the potential mechanism is ROS-mediated Wnt/β-catenin signaling pathway. Toxicol Appl Pharmacol. 2012;262:11–21.
48. Kopec AK, Kim S, Forgacs AL, et al. Genome-wide gene expression effects in B6C3F1 mouse intestinal epithelia following 7 and 90 days of exposure to hexavalent chromium in drinking water. Toxicol Appl Pharmacol. 2012;259:13–26.
49. Reynolds M, Peterson E, Quievryn G, et al. Human nucleotide excision repair efficiently removes chromium-DNA phosphate adducts and protects cells against chromate toxicity. J Biol Chem. 2004;279:30419–24.
50. Reynolds M, Zhitkovich A. Cellular vitamin C increases chromate toxicity via a death program requiring mismatch repair but not p53. Carcinogenesis. 2007;28:1613–20.
51. Reynolds MF, Peterson-Roth EC, Bespalov IA, et al. Rapid DNA double-strand breaks resulting from processing of Cr-DNA cross-links by both MutS dimers. Cancer Res. 2009;69:1071–9.
52. Peterson-Roth E, Reynolds M, Quievryn G, et al. Mismatch repair proteins are activators of toxic responses to chromium-DNA damage. Mol Cell Biol. 2005;25:3596–607.
53. Coogan TP, Motz J, Snyder CA, et al. Differential DNA-protein crosslinking in lymphocytes and liver following chronic drinking water exposure of rats to potassium chromate. Toxicol Appl Pharmacol. 1991;109:60–72.
54. Cheng L, Sonntag DM, de Boer J, et al. Chromium(VI)-induced mutagenesis in the lungs of big blue transgenic mice. J Environ Pathol Toxicol Oncol. 2000;19:239–49.
55. Kondo K, Hino N, Sasa M, et al. Mutations of the p53 gene in human lung cancer from chromate-exposed workers. Biochem Biophys Res Commun. 1997;239:95–100.
56. O’Brien TJ, Ding H, Suh M, et al. Assessment of K-Ras mutant frequency and micronucleus incidence in the mouse duodenum following 90-days of exposure to Cr(VI) in drinking water. Mutat Res. 2013;754:15–21.
57. Wise SS, Wise JP. Chromium and genomic stability. Mutat Res. 2012;733:78–82.
58. Thompson CM, Haws LC, Harris MA, et al. Application of the U.S. EPA mode of action framework for purposes of guiding future research: a case study involving the oral carcinogenicity of hexavalent chromium. Toxicol Sci. 2011;119:20–40. The study analyzed the key events in Cr(VI) MOA underlying mouse intestinal tumors, and pointed out the major data gaps and possible research strategies to establish Cr(VI) MOA.
59. Thompson CM, Seiter J, Chappell MA, et al. Synchrotron-based imaging of chromium and γ-H2AX immunostaining in the duodenum following repeated exposure to Cr(VI) in drinking water. Toxicol Sci. 2015;143:16–25.
60. Proctor DM, Otani JM, Finley BL, et al. Is hexavalent chromium carcinogenic via ingestion? A weight-of-evidence review. J Toxicol Environ Health A. 2002;65:701–46.
61. Paustenbach DJ, Finley BL, Mowat FS, et al. Human health risk and exposure assessment of chromium (VI) in tap water. J Toxicol Environ Health A. 2003;66:1295–339.
62. Stern AH. A quantitative assessment of the carcinogenicity of hexavalent chromium by the oral route and its relevance to human exposure. Environ Res. 2010;110:798–807.
63. Arita A, Costa M. Epigenetics in metal carcinogenesis: nickel, arsenic, chromium and cadmium. Metallomics. 2009;1:222–8.
64. Brocato J, Costa M. Basic mechanics of DNA methylation and the unique landscape of the DNA methylome in metal-induced carcinogenesis. Crit Rev Toxicol. 2013;43:493–514.
65. Rodríguez-Paredes M, Esteller M. Cancer epigenetics reaches mainstream oncology. Nat Med. 2011;17:330–9.
66. Klein CB, Su L, Bowser D, et al. Chromate-induced epimutations in mammalian cells. Environ Health Perspect. 2002;110 Suppl 5:739–43.
67. Kondo K, Takahashi Y, Hirose Y, et al. The reduced expression and aberrant methylation of p16(INK4a) in chromate workers with lung cancer. Lung Cancer. 2006;53:295–302.
68. Takahashi Y, Kondo K, Hirose T, et al. Microsatellite instability and protein expression of the DNA mismatch repair gene, hMLH1, of lung cancer in chromate-exposed workers. Mol Carcinog. 2005;42:150–8.
69. Ali AH, Kondo K, Namura T, et al. Aberrant DNA methylation of some tumor suppressor genes in lung cancers from workers with chromate exposure. Mol Carcinog. 2011;50:89–99.
70. Sun H, Kluz T, Qu Q, et al.: DNA hypermethylation of tumor suppressor genes in chromate workers (abstract #969). Society of Toxicology. 2014; Pheonix, AZ.
71. Wang TC, Song YS, Wang H, et al. Oxidative DNA damage and global DNA hypomethylation are related to folate deficiency in chromate manufacturing workers. J Hazard Mater. 2012;213–214:440–6.
72. Lou J, Wang Y, Yao C, et al. Role of DNA methylation in cell cycle arrest induced by Cr (VI) in two cell lines. PLoS One. 2013;8, e71031.
73. Xia B, Yang LQ, Huang HY, et al. Chromium(VI) causes down regulation of biotinidase in human bronchial epithelial cells by modifications of histone acetylation. Toxicol Lett. 2011;205:140–5.
74. Xia B, Ren XH, Zhuang ZX, et al. Effect of hexavalent chromium on histone biotinylation in human bronchial epithelial cells. Toxicol Lett. 2014;228:241–7.
75. Sun H, Zhou X, Chen H, et al. Modulation of histone methylation and MLH1 gene silencing by hexavalent chromium. Toxicol Appl Pharmacol. 2009;237:258–66.
76. Zhou X, Li Q, Arita A, et al. Effects of nickel, chromate, and arsenite on histone 3 lysine methylation. Toxicol Appl Pharmacol. 2009;236:78–84.
77. He J, Qian X, Carpenter R, et al. Repression of miR-143 mediates Cr (VI)-induced tumor angiogenesis via IGF-IR/IRS1/ERK/IL-8 pathway. Toxicol Sci. 2013;134:26–38.
78. Li Y, Li P, Yu S, et al. miR-3940-5p associated with genetic damage in workers exposed to hexavalent chromium. Toxicol Lett. 2014;229:319–26.